Patents by Inventor Alison Jane FORGIE

Alison Jane FORGIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-GLUCAGON RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20160311912
    Abstract: The present invention provides antagonizing antibodies that bind to glucagon receptor and methods of using same. The anti-glucagon receptor antibodies can be used therapeutically to lower glucose levels in blood, and can be in the prevention and/or treatment of glucose-related disorders, including diabetes, hyperglycemia, hyperinsulinemia, impaired fasting glucose, impaired glucose tolerance, dyslipidemia, or metabolic syndrome.
    Type: Application
    Filed: December 21, 2015
    Publication date: October 27, 2016
    Inventors: Alison Jane Forgie, Javier Fernando Chaparro Riggers, Edward Roland Lavallie, Chia-Yang Lin, Lidia Mosyak, Andrea Rossi, Thomas John Van Blarcom
  • Anti-glucagon receptor antibodies and pharmaceutical compositions thereof
    Patent number: 9248189
    Abstract: The present invention provides antagonizing antibodies that bind to glucagon receptor and methods of using same. The anti-glucagon receptor antibodies can be used therapeutically to lower glucose levels in blood, and can be in the prevention and/or treatment of glucose-related disorders, including diabetes, hyperglycemia, hyperinsulinemia, impaired fasting glucose, impaired glucose tolerance, dyslipidemia, or metabolic syndrome.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: February 2, 2016
    Assignee: PFIZER INC.
    Inventors: Alison Jane Forgie, Javier Fernando Chaparro Riggers, Edward Roland Lavallie, Chia-Yang Lin, Lidia Mosyak, Andrea Rossi, Thomas John Van Blarcom
  • ANTI-GLUCAGON RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20140335091
    Abstract: The present invention provides antagonizing antibodies that bind to glucagon receptor and methods of using same. The anti-glucagon receptor antibodies can be used therapeutically to lower glucose levels in blood, and can be in the prevention and/or treatment of glucose-related disorders, including diabetes, hyperglycemia, hyperinsulinemia, impaired fasting glucose, impaired glucose tolerance, dyslipidemia, or metabolic syndrome.
    Type: Application
    Filed: May 2, 2014
    Publication date: November 13, 2014
    Applicant: RINAT NEUROSCIENCE CORP.
    Inventors: Alison Jane FORGIE, Javier Fernando CHAPARRO RIGGERS, Edward Roland LAVALLIE, Chia-Yang LIN, Lidia MOSYAK, Andrea ROSSI, Thomas John VAN BLARCOM